MicroRNA-761 is Upregulated in Hepatocellular Carcinoma and Regulates Tumorigenesis by Targeting Mitofusin-2
Overview
Authors
Affiliations
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the third leading cause of cancer-related deaths worldwide. The fate of a cell is determined by the balance between the processes of fission and fusion that constantly occur in the mitochondria of cells. We previously showed that overexpression of Mitofusin-2 can induce apoptosis in HCC cells by triggering an influx of Ca(2+) into the mitochondria from the ER. The function of Mitofusin-2 has been studied extensively, but the mechanism underlying the post-transcriptional regulation of Mitofusin-2 has not been elucidated. In the present study, we aimed to identify the mechanism of Mitofusin-2 regulation in HCC. We demonstrated that Mitofusin-2 is a direct target of miR-761, which was found to be upregulated in HCC tissues. Furthermore, a miR-761 inhibitor impaired mitochondrial function by upregulating Mitofusin-2 and effectively repressed tumor growth and metastasis both in vivo and in vitro. Our findings provide new insight into the mechanism underlying Mitofusin-2 regulation and the potential role of miR-761 in HCC, making it a potential candidate for use in HCC therapy in the future.
The "LINC" between Δ40p53-miRNA Axis in the Regulation of Cellular Homeostasis.
Pal A, Ghosh P, Das S Mol Cell Biol. 2023; 43(7):335-353.
PMID: 37283188 PMC: 10348045. DOI: 10.1080/10985549.2023.2213147.
Mitochondria-associated endoplasmic reticulum membrane: Overview and inextricable link with cancer.
Yang X, Zhuang J, Song W, Shen W, Wu W, Shen H J Cell Mol Med. 2023; 27(7):906-919.
PMID: 36852470 PMC: 10064038. DOI: 10.1111/jcmm.17696.
Prognostic impact of mitofusin 2 expression in colon cancer.
Cheng X, Li Y, Liu F Transl Cancer Res. 2022; 11(10):3610-3619.
PMID: 36388028 PMC: 9641083. DOI: 10.21037/tcr-22-589.
Mitochondrial dynamics involves molecular and mechanical events in motility, fusion and fission.
Green A, Hossain T, Eckmann D Front Cell Dev Biol. 2022; 10:1010232.
PMID: 36340034 PMC: 9626967. DOI: 10.3389/fcell.2022.1010232.
Zhou X, Xu H, Xu C, Yan Y, Zhang L, Sun Q World J Emerg Med. 2022; 13(5):379-385.
PMID: 36119773 PMC: 9420661. DOI: 10.5847/wjem.j.1920-8642.2022.089.